SC1-BHC-01-2019
SC1-BHC-01-2019
13 projects · €79,100,694 total EU contribution (project-level) · 170 participating organizations · 26 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€79,100,694
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (26)
- Netherlands (24)
- Spain (20)
- UK (16)
- Italy (15)
- Germany (13)
- BE (9)
- CH (6)
- EL (5)
- IE (5)
- NO (5)
- SE (4)
- DK (3)
- FI (3)
- IS (3)
- ME (2)
- US (2)
- AT (1)
- EE (1)
- HU (1)
- IL (1)
- JP (1)
- LU (1)
- PL (1)
- PT (1)
- RO (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM4 projects · FR
- KING'S COLLEGE LONDON4 projects · UK
- CNRS3 projects · FR
- KI3 projects · SE
- STICHTING AMSTERDAM UMC3 projects · NL
- RADBOUDUMC3 projects · NL
- STICHTING RADBOUD UNIVERSITEIT3 projects · NL
- UNIVERSITEIT MAASTRICHT3 projects · NL
- UNIVERSITY COLLEGE LONDON3 projects · UK
- CSIC2 projects · ES
- AX2 projects · ES
- ARTTIC2 projects · FR
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity PainFACT · 848099 | H2020 | €6,000,000 | €418,750 | Details |
Brain Involvement iN Dystrophinopathies BIND · 847826 | H2020 | €6,666,325 | €500,201 | Details |
Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia RECOGNISED · 847749 | H2020 | €5,998,273 | €229,673 | Details |
Gene overdosage and comorbidities during the early lifetime in Down Syndrome GO-DS21 · 848077 | H2020 | €5,965,968 | €567,999 | Details |
MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure CRUCIAL · 848109 | H2020 | €6,000,000 | €20,000 | Details |
A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities TO_AITION · 848146 | H2020 | €5,990,515 | €458,155 | Details |
Prevention and Remediation of Insulin Multimorbidity in Europe PRIME · 847879 | H2020 | €6,000,000 | €246,113 | Details |
Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity EarlyCause · 848158 | H2020 | €5,997,381 | €554,404 | Details |
Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy CANDY · 847818 | H2020 | €6,000,000 | €825,000 | Details |
COMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE AND-PD · 848002 | H2020 | €5,995,849 | €400,044 | Details |